UK REACH authorisations for Siemens Healthcare Diagnostics Products GmbH, 3 July 2024
Decision on application for authorisations under UK REACH.
Documents
Details
Decision on an application for authorisations under UK REACH.聽
Substance name聽
4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO).聽
Authorised uses
Use of 4-tert-OPnEO in in-vitro diagnostic (IVD) kit reagents on diagnostic analyser systems used in controlled settings by professional users such as hospitals and pharmacies.聽
Use of 4-tert-OPnEO as a cleaning surfactant in IVD wash solutions on diagnostic analyser systems to ensure their continued accuracy in controlled settings by professional users such as hospitals and pharmacies.聽
Holder of the authorisations and authorisation numbers聽
Siemens Healthcare Diagnostics Products GmbH (UKREACH/24/06/0, UKREACH/24/06/1).聽
Date of decision聽
3 July 2024.
Updates to this page
-
We have corrected incorrect dates in paragraphs 3 and 4 of the decision report. 皇冠体育app deadlines to submit review reports for Uses 1 and 2 have been changed from 鈥�31 June 2031鈥� and 鈥�31 June 2024鈥�, to 鈥�1 July 2031鈥� and 鈥�1 July 2024鈥�. 皇冠体育app changes do not affect the decision, nor the review periods granted to the applicant.
-
First published.